Jupiter NeurosciencesJUNS

13F holders, Q1 2026 (March 31)
10holders −2
3new positions
6sold out
1famous investor
$0.38avg. 13F price*

At the end of Q1 2026, 10 institutions reported holding Jupiter Neurosciences Inc. (JUNS) in their 13F filings, down 2 from Q4 2025. 3 opened new positions and 6 sold out. The largest holders were Vestor Capital, LLC ($365K), Vanguard Capital Management LLC ($135K) and Geode Capital Management, LLC ($80K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Jupiter Neurosciences Inc.
CUSIP
48208B203
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q4 2024: 3Q4 2024Q1 2025: 7Q1 2025Q2 2025: 2Q2 2025Q3 2025: 9Q3 2025Q4 2025: 12Q4 2025Q1 2026: 10Q1 2026Q2 2026: 13Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions3$45K
Exits6$100K

All 13F filers, Q4 2025 → Q1 2026: 1,168,533 shares bought and 101,282 shares sold, net +1,067,251 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Vestor Capital, LLC 0.03% Add +144607.1% 970,985 $365K
Vanguard Capital Management LLC 0.00% — 359,911 $135K
Geode Capital Management, LLC 0.00% Add +59.6% 211,696 $80K
Yorkville Advisors Global, LP 0.03% Reduce -2.2% 129,000 $49K
Citadel Advisors 0.00% New 101,661 $38K
Vanguard Fiduciary Trust Co. 0.00% — 87,789 $33K
Northern Trust Corp. 0.00% No change 25,346 $10K
Virtu Financial LLC 0.00% New 13,575 $5K
UBS Group AG 0.00% New 3,928 $1K
MidFirst Bank 0.00% No change 1,000 $376

"% of holder's portfolio" is JUNS's weight in each manager's 13F, not the share of Jupiter Neurosciences Inc. the manager owns.